21-(ACETYLOXY)-9-BROMO-11,16,17-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII 8L4WB2N89A
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-(acetyloxy)-9-bromo-11,16,17-trihydroxypregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8L4WB2N89A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 91160-89-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H29BrO7 LTRVYEKAPGRFOX-QZUYBKCWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-(acetyloxy)-9-bromo-11,16,17-trihydroxypregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.